ÂÜÀòÂÒÂ×

Yujin Wang has extensive experience in the biopharmaceutical industry, currently serving as Sr. Director of DMPK/bioanalysis at Day One Biopharmaceuticals. Previous roles include Director of DMPK at Brii Biosciences and Associate Director positions at both Terns Pharmaceuticals and Brii Biosciences. Yujin Wang began a career at Gilead Sciences as an Associate Scientist II and held the position of Research Associate at Pharmacyclics. This diverse background encompasses significant expertise in drug metabolism and pharmacokinetics (DMPK) and bioanalysis.